Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)

American Journal of Hematology

Volumn 65, Issue 2, 2000, Pages 154-159

  Triplett, Douglas A ^a   Asherson, Ronald A ^b  

^a BALL MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

CAPS; Phospholipid antibodies; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; STEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; DIFFERENTIAL DIAGNOSIS; HUMAN; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; REVIEW; TERMINAL DISEASE; THROMBOPHILIA; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; THROMBOSIS;

EID: 0033824676     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200010)65:2<154::AID-AJH11>3.0.CO;2-A     Document Type: Review

References (51)

1. Thrombosis and systemic lupus erythematosus despite circulating anticoagulants
2. Peripheral vascular syndromes associated with systemic lupus erythematosus
3. Acquired inhibitors of blood coagulation
4. Thrombosis in patients with the lupus anticoagulant
5. Antiphospholipid (Hughes') syndrome
6. Hughes' syndrome - The antiphospholipid syndrome: A historical view
7. A 'primary' antiphospholipid syndrome?
8. Primary antiphospholipid syndrome
9. The primary antiphospholipid syndrome. Major clinical and serological features
10. Primary antiphospholipid syndrome. Features of patients with raised anticardiolipin antibodies and no orther disorder
11. Avortements a repetition, thromboses effort tolerance anticoagulant circulant antithromboplastine. Trois observations
12. The anticardiolipin syndrome
13. Clinical and serological features of the antiphospholipid syndrome
14. The antiphospholipid/protein syndrome
15. The antiphospholipid/co-factor syndromes
16. Hughes' syndrome: Antiphospholipid antibodies move closer to thrombosis in 1994
17. Antibody-mediated thrombosis
18. The catastrophic antiphospholipid syndrome
19. The catastrophic antiphospholipid syndrome in 1996. Acute multiorgan failure associated with antiphospholipid antibodies. A review of 31 patients
20. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients
21. The catastrophic antiphospholipid syndrome 1998. A review of the clinical features, possible pathogenesis and treatment
22. Predictive factors and prevention of catastrophic antiphospholipid syndrome
23. Thrombotic storm. When thrombosis begets thrombosis
24. Acalculous ischaemic gall bladder necrosis in the catastrophic antiphospholipid syndrome
25. Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever. A possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy
26. Three episodes of multiorgan failure in a woman with secondary antiphospholipid syndrome
27. The role of microvasculopathy in the catastrophic antiphospholipid syndrome: Comment on the article by Neuwelt et al
28. Antiphospholipid antibodies, lupus anticoagulants and thromboembolic disease
29. 2-Glycoprotein I: Target antigen for antiphospholipid antibodies. Immunological and molecular aspects
30. 2-glycoprotein I in the expression of lupus anticoagulant activity
31. Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties
32. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex
33. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: Interactions of inflammatory cells and activated endothelium
34. Endothelial cells as target for antiphospholipid antibodies
35. 2-glycoprotein I antibody affinity
36. Role of phosphatidylethanolamine in inhibition of activated protein C activity by antiphospholipid antibodies
37. Role of caspases I and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated microangiopathies
38. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells
39. Lupus anticoagulant autoantibody induced apoptosis in umbilical vein endothelial cells: Involvement of annexin V
40. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism?
41. Antiphospholipid antibodies and myocardial infarction
42. Multiorgan thrombotic disorders in systemic lupus erythematosus: A common link?
43. Heparin-induced thrombocytopenia
44. 2-Glycoprotein I deficiency and the risk of thrombosis
45. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
46. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
47. Moschcowitz, multimers, and metalloprotease
48. Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination
49. Disseminated intravascular coagulation: Clinical and laboratory aspects
50. World distribution of factor V Leiden
51. Therapeutic use of single-stranded naked, denatured DNA (defibrotid, DF) in antiphospholipid antibody syndrome (APLAS)